Opioid-induced constipation in internal medicine: recognition and management pathways
Internal and Emergency Medicine · 2025-09 · 20 (6) · 1695-1704
DOI: 10.1007/s11739-025-04091-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Internal and Emergency Medicine, online erschienen am 28.08.2025. Verfasst von Piero Portincasa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine 'A. Murri' and Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari 'Aldo …. Hauptthemen laut MEDLINE: Opioid-Induced Constipation, Analgesics, Opioid, Constipation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Bari Aldo Moro.
Abstract (Originalsprache)
Opioid-induced constipation (OIC) remains one of the most frequent and distressing gastrointestinal side effects encountered by patients on chronic opioid therapy. Despite the high prevalence, OIC is frequently underdiagnosed and inadequately managed, with critical effects on the quality of life of patients. Aim of this review is to promote the awareness about OIC in the context of internal medicine. We examined the statement EnhanCing Healthcare Outcomes in Opioid-Induced Constipation (ECHO OIC) by European experts to streamline the diagnosis and management of OIC in clinical practice. Such guidelines have been further discussed by an Italian expert consensus to provide national customization and a multidisciplinary approach. The key finding is the implementation of a multi-step clinical pathway for prevention, diagnosis, treatment, and long-term management of OIC, taking into account the improvement of quality of life of patients. In conclusion, we urge to expand awareness about OIC. The seven-step diagnostic–therapeutic pathway approach formulated by ECHO OIC is a pragmatic and scalable model to improve OIC management with emphasis on education, early intervention, monitoring, tailored pharmacologic strategies, and coordinated referral when necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Internal Medicine 'A. Murri' and Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari 'Aldo Moro', Bari, Italy. piero.portincasa@uniba.it.
- Division of Internal Medicine 'A. Murri' and Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari 'Aldo Moro', Bari, Italy.
- Department of Medicine, VA Boston Healthcare System, Boston, MA, USA.
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Piero Portincasa
Förderung
- Università degli Studi di Bari Aldo Moro
Zitieren
APA
Portincasa, P., Luglio, C. V., Sozzi, S., Conforti, C., Bitonto, G., Papavero, M., Baffy, G., & Di Ciaula, A. (2025). Opioid-induced constipation in internal medicine: recognition and management pathways. Internal and Emergency Medicine, 20(6), 1695-1704. https://doi.org/10.1007/s11739-025-04091-2
Vancouver
Portincasa P, Luglio CV, Sozzi S, Conforti C, Bitonto G, Papavero M, et al. Opioid-induced constipation in internal medicine: recognition and management pathways. Internal and Emergency Medicine. 2025;20(6):1695-1704. doi:10.1007/s11739-025-04091-2
BibTeX
@article{Portincasa2025,
author = {Portincasa, Piero and Luglio, Chiara Valentina and Sozzi, Silvia and Conforti, Claudia and Bitonto, Gianluca and Papavero, Michele and Baffy, Gyorgy and Di Ciaula, Agostino},
title = {Opioid-induced constipation in internal medicine: recognition and management pathways},
journal = {Internal and Emergency Medicine},
year = {2025},
volume = {20},
number = {6},
pages = {1695--1704},
doi = {10.1007/s11739-025-04091-2}
}
EUVIMED